Novartis CEO says US manufacturing investments and a federal agreement could limit tariff exposure as proposed Trump levies target Europe.

MSN Laboratories Pvt. Ltd. can’t reopen disputes resolved in earlier litigation over the scope, validity, and infringement of ...

We recently compiled a list of the Top 10 Oncology Stocks to Buy Now. Novartis AG is placed ninth on our list among the best cancer stocks. TheFly reported on January 6 that Barclays upgraded NVS to ...

Novartis NVS announced that the FDA granted Breakthrough Therapy designation to its pipeline candidate, ianalumab for the ...

Novartis AG (NYSE:NVS) on Thursday unveiled a sweeping $23 billion investment plan to expand its manufacturing and research infrastructure in the U.S. over the next five years. The move is part of a ...

Novartis to acquire Avidity for USD 72.00 per share in cash for total equity value of approximately USD 12.0 billion Avidity expects to separate its early-stage precision cardiology programs into a ...

Fintel reports that on January 6, 2026, Barclays upgraded their outlook for Novartis AG - Depositary Receipt (NYSE:NVS) from Underweight to Equal-Weight. Analyst Price Forecast Suggests 5.08% Downside ...

New 35,000-square-foot facility in Winter Park will expand RLT manufacturing footprint to optimize delivery for patients across southeastern USPurpose-built facility will strengthen Novartis RLT ...

Loomis Sayles, an investment management company, released its “Global Growth Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. In the first quarter, the fund ...

ZAPO:CAApollo Global Management, Inc. Apollo Global Management, Inc. ZHOO:CARobinhood Markets, Inc. Robinhood Markets, Inc. INGS:CAING Groep N.V. ING Groep N.V.

Defendants MSN Laboratories Private Limited, MSN Pharmaceuticals Inc., and Novadoz Pharmaceuticals LLC moved to stay the preliminary injunction granted to plaintiffs Novartis AG and Novartis ...